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CASE REPORT
A germ cell tumor in a patient 
with swyer syndrome with ambiguous genitalia
Dharshana Tharanga Kulathilake* and Champa Jayasundara
Abstract 
Background: Swyer syndrome is a rare manifestation of disorders of sex development in which the individual is 
46, XY in genotype but phenotypically a female. They have normal female external genitalia with under developed 
female internal genitalia. They usually present with primary amenorrhoea and delayed puberty but also can present 
with gonadal tumors in adult life.
Case presentation: A 25-year-old Sri Lankan phenotypically female having 46 XY karyotype with a history of primary 
amenorrhoea, presented with left loin pain associated with fever. General examination revealed a tall stature, scanty 
axillary and pubic hair, small breasts and clitoromegally. A tender ill-defined mass was detected in the left hypochon-
drial region. She had high erythrocyte sedimentation rate with elevated alkaline phosphatase and lactate dehydroge-
nase levels. Her serum hormonal assay revealed a low estradiol level with elevated luteinizing hormone and follicular 
stimulating hormone levels with normal progesterone and testosterone levels. Computerized tomography of abdo-
men showed a large complex mass lesion in relation to antero-medial aspect of the lower pole of the left kidney with 
para-aortic and left common iliac lymph nodes. The diagnostic laparoscopy confirmed the presence of internal female 
genitalia and the mass lesion was seen in left para-aortic region. The histology revealed a germ cell tumor compatible 
with a dysgerminoma.
Conclusion: Patients with Swyer syndrome can present with gonadal tumors, typically a dysgerminoma in their adult 
life.
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Background
Swyer syndrome or 46, XY complete gonadal dysgenesis 
(46, XY CGD) is a disorder of sex development (DSD) in 
which the individual is 46, XY in genotype but pheno-
typically a female. They have unambiguous female exter-
nal genitalia and normal Müllerian structures. Mutations 
in the genes SRY, DAX1, WNT4, SOX9, SF1, WT1 and 
WMRT1—WMRT2 in chromosome Y have been con-
sidered responsible for the development of 46, XY CGD. 
Patients with Swyer syndrome show hypergonadotrophic 
hypogonadism with low levels of estrogens and normal 
female levels of androgens and they usually present with 
primary amenorrhoea and delayed puberty. The syn-
drome may also present in late adulthood with gonadal 
tumors, typically a dysgerminoma. We report a case of a 
23-year-old phenotypic female with 46, XY genotype and 
female internal genitalia, ambiguous external genitalia 
(clitoromegally) presenting with a germ cell tumor in an 
unusual site, considered as a dysgerminoma in a case of 
Swyer’s syndrome.
Case presentation
A 25-year-old Sri Lankan phenotypically female pre-
sented to the general medical unit with the complaint 
of gradual onset left loin pain associated with fever 
for 5  days. It was a moderate to severe dull ache which 
did not radiate to groin. The fever was intermittent and 
associated with chills but not with rigors. She did not 
experience urinary symptoms like dysuria, increased 
urinary frequency or hematuria. She has had few epi-
sodes of vomiting associated with the abdominal pain 
but her bowel opening was normal. She’s an unmarried, 
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nulliparous female and further inquiry revealed that 
she had been investigated for primary amenorrhoea at 
the age of 14 years. She was found to have rudimentary 
uterus with intact ovaries ultrasonically and was ini-
tially started on combined oral contraceptive pills. With 
the medication she started normal menstruation but the 
treatment was not regularly taken due to the appearance 
of acne and weight gain. At the age of 23 years she was 
referred to an Endocrinologist and found to have 46, XY 
genotype by chromosomal analysis. She was given estra-
diol valerate titrating doses by the physician but treat-
ment was defaulted by the patient due to fear of cancer 
risk.
On examination she was 66 kg in weight and 170.2 cm 
in height (BMI  =  22.84  kg/m2). She had small breasts, 
scanty axillary hair and scanty female pattern pubic 
hair. Her external genitalia were female in type but clito-
romegally was observed. She was febrile but not pale or 
icteric. Cervical lymphadenopathy was not detected. A 
tender mass with smooth surface was palpated over left 
hypochondrium which was not ballotable and the upper 
margin was not detected by palpation or by percussion. 
There was no hepatomegaly. Her cardiovascular, respira-
tory neurological and loco-motor system examinations 
were unremarkable.
Investigations revealed a total white cell count of 
7.6 × 109/ml (neutrophils—75.3 %, lymphocytes—13.9 %, 
monocytes—8.3  % and eosinophils—2.4  %), hemo-
globin of 11.5 g/dl and a platelet count of 243 × 109/ml. 
Erythrocyte sedimentation rate was 127 mm in 1st hour. 
Liver profile revealed alkaline phosphatase (ALP) level 
of 2986 U/L with slightly elevated transaminase levels 
(alanineaminotransferase—60 U/L and aspartate ami-
notransferase—47 U/L). Renal and coagulation profiles 
were normal. Serum lactate dehydrogenase (LDH) level 
was 395 U/L. Serum tumor markers including alpha-feto 
protein (AFP) levels, serum beta- human chorionic gon-
adotropin (hCG) and CA 125 levels were within normal 
range. The chest and lumbo-sacral spine roentgenograms 
were reported as normal. Ultrasound scan of abdomen 
and pelvis revealed a well-defined mass lesion in rela-
tion to the lower pole of the left kidney. Small uterus 
was visualized but ovaries could not be identified sepa-
rately. The liver was normal in size and there were no 
focal lesions. Contrast enhanced computerized tomogra-
phy of abdomen and pelvis revealed large complex mass 
lesion (11.0 × 9.7 × 8.3 cm) in relation to antero-medial 
aspect of the lower pole of the left kidney (Fig.  1). Few 
para-aortic and left common iliac lymph nodes were also 
detected.
Her serum hormonal assay revealed a low estradiol 
level of 9.0  pg/ml (normal range: 39–189  pg/ml in fol-
licular phase) in the background of elevated luteinizing 
hormone level of 40.64 μIU/ml (2–15 μIU/ml in follicular 
phase) and follicular stimulating hormone level of 73.09 
μIU/ml (3–20 μIU/ml in follicular phase). The proges-
terone level of 0.35  ng/ml (0.33–1.2  ng/ml in follicular 
phase) and testosterone level of 0.25  ng/ml (0–0.73  ng/
Fig. 1 Contrast enhanced computerized tomographic image of the tumor. Contrast enhanced computerized tomography of abdomen and pelvis 
showing large tumor in relation to the lower pole of the left kidney
Page 3 of 5Kulathilake and Jayasundara  BMC Res Notes  (2015) 8:747 
ml) were within normal range. She was found to have 
normal thyroid stimulating hormone level of 2.55 μIU/ml 
(0.4–5.1 μIU/ml) and serum prolactin level of 18.5 ng/ml 
(3.9–29.5 ng/ml).
Diagnostic laparoscopy revealed a small uterus with 
bilateral normal sized ovaries with fallopian tubes. The 
mass lesion revealed by imaginary studies was confirmed 
as a para-aortic mass but which was not attached to the 
lower pole of the left kidney. The left gonadal vein was 
seen crossing over the mass. Excision of the left para-
aortic mass with attached lymph nodes was done via a 
subcostal incision which extended up to the xyphister-
num. Pathological sectioning of the mass macroscopi-
cally showed a soft degenerating tumor with a uniform 
red-brown appearance (Fig.  2a). A uniform, firm, yel-
low- white separate lobule was seen outside the capsule 
measuring 4.0 × 3.0 × 2.8 cm (Fig. 2b). Five lymph nodes 
were dissected from the loose connective tissue outside 
the capsule. Sections of large red brown mass showed a 
necrotic mass of tumor with few areas of viable tissue. 
Adjacent white lobule showed viable tumor tissue com-
patible with germ cell tumor consistent with a seminoma 
or dysgerminoma (Fig.  3). Tumor nodules were noted 
within the capsule and were seen to infiltrate beyond the 
capsule into adjacent connective tissue. No vascular or 
perineural invasion was noted. Normal testicular or ovar-
ian tissue was not detected within the tumor mass. Four 
out of five lymph nodes showed tumor deposits within 
which two nodes were extensively involved by the tumor.
The differential diagnosis of Swyer syndrome (46, 
XY complete gonadal dysgenesis), 46, XY disorder of 
sex development (46, XY DSD) and partial androgen 
insensitivity syndrome were made. Androgen insensi-
tivity syndrome was easily excluded since the presence 
of female internal genital organs. Even though the pres-
ence of clitoromegally is against the diagnosis of Swyer 
syndrome, 46, XY DSD could be fairly excluded due to 
the absence of testicular elements via direct visualiza-
tion of the abdominal cavity and by histology. The treat-
ing oncologist decided to preserve the ovaries and the 
patient was given full course of chemotherapy.
Discussion
Swyer syndrome or 46, XY CGD is a disorder of sex 
development (DSD) in which the individual is 46, XY 
in genotype but phenotypically a female with unam-
biguous female external genitalia and normal Müllerian 
structures. These patients’ mesonephric ducts (Wolffian 
Fig. 2 Macroscopic view of the tumor. A well encapsulated vaguely lobulated mass with a smooth surface measuring 11.0 cm × 10.5 cm × 9.0 cm 
(a). Cut section showing a uniform red-brown necrotic mass with a firm, yellow-white separate lobule outside the capsule measuring 
4.0 cm × 0.0 cm × 2.8 cm (b)
Fig. 3 Microscopic view of the tumor. Microscopy of the yellow-white 
lobule showing large vesicular cells with clear cytoplasm well defined 
cell boundaries and centrally placed regular nuclei. The stroma is 
infiltrated with lymphocytes
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ducts) get atrophied while paramesonephric ducts (Mül-
lerian ducts) develop into uterus, fallopian tubes and 
vagina in the absence of testosterone and anti-Müllerian 
hormone. However, such female patients, in the absence 
of XX chromosome do not have a properly developed 
uterus and ovaries.
Mutations in the SRY gene in chromosome Y have 
been implicated as the basic etiology, but duplication 
of DAX1 (also known as NROB1) and WNT4 genes as 
well as haplo-insufficiency of the SOX9, SF1, WT1 and 
WMRT1—WMRT2 genes are also have been considered 
responsible for the development of 46, XY CGD [1]. SRY 
gene plays a pivotal role in human testis development and 
its inactivation mutations will lead to complex XY sex 
reversal as seen in 46, XY CGD. But the mutations in the 
SRY gene are found only in 10–20 % of cases of 46, XY 
CGD [2]. The majority are located within the HMG box, 
a DNA binding domain which acts as a modulating local 
chromatin structure in order to transcribe adjacent target 
genes. The majority of mutations are de novo, yet there is 
a subset of cases where the mutation runs in families, but 
index cases are been borne to phenotypically normal and 
fertile fathers. One explanation for these familial cases is 
paternal gonadal mosaicism [3]. The incidence of Swyer 
syndrome is 1:100,000 [4].
Patients with Swyer syndrome show hypergonador-
trophic hypogonadism with low levels of estrogens and 
normal female levels of androgens. Their minimal breast 
development is a result of peripheral aromatization of 
androgens. They have scanty pubic and axillary hair and 
are taller than the ordinary females. Their gonads (ova-
ries) display fibrous tissue but no follicles [5].
They usually present with primary amenorrhoea and 
delayed puberty. The syndrome may also present in late 
adulthood with gonadal tumors, typically a dysgermi-
noma. Other tumors with which they can manifest are 
gonadoblastoma, teratoma and embryonic carcinoma. The 
lifetime risk of gonadal tumors is in range of 15–35 % [3].
Since the Müllerian structures are preserved in Swyer 
syndrome the uterus may increase in size when estrogen 
replacement is started and successful pregnancies have 
been achieved following egg donation.
46, XY partial gonadal dysgenesis, which is now called 
as 46, XY disorder of sex development (46, XY DSD) is 
also a DSD associated with anomalies in gonadal devel-
opment that results in genital ambiguity of variable 
degree ranging from clitoromegally in female phenotype 
to absolute male phenotype in a patient with 46, XY kar-
yotype. It is associated with abnormality of both Leidig 
and Sertoli cell function that may result from deletions 
or point mutations in the SRY gene or dose sensitive 
(RROB1) locus duplication on the X chromosome [6]. 
These patients have dysgenetic gonads with testicular ele-
ments with reduced to absent sperm production. Mülle-
rian structures including uterus and fallopian tubes may 
or may not be present in these cases.
Ovarian germ cell tumors are derived from primor-
dial germ cell tumors of the ovary and can be benign 
or malignant. Dysgerminomas are the female version 
of the male seminoma and are essentially composed 
of immature germ cells. They can occur at any age but 
have a predilection for young women. Grossly, dysger-
minoma appears as a lobulated mass that is firm and 
cream colored or pale tan. Histologically, the neoplasm is 
composed of undifferentiated germ cells, large vesicular 
cells with clear cytoplasms, well defined cell boundaries 
and centrally placed regular nuclei. The overall picture 
is also described as “fried-eggs” appearance. The stroma 
is infiltrated by clusters of small lymphocytes and fre-
quently contains granulomas. Due to the rapid growth of 
dysgerminoma, patients usually present with abdominal 
enlargement and pain due to rupture with hemoperito-
neum or torsion. Dysgerminomas can contain syncy-
tiotrophoblastic giant cells those produce placental ALP 
and LDH. In addition, 3–5 % of dysgerminomas produce 
hCG, but in general, they do not produce AFP [7]. Sur-
gery is performed for definitive diagnosis, staging and 
initial treatment of dysgerminomas.
Dysgerminomas may develop within a gonadoblastoma 
(a benign or in  situ germ cell ovarian neoplasm com-
posed of germ cells and sex cord stroma) in phenotypic 
females who have a Y chromosome. This group includes 
patients with 46, XY complete gonadal dysgenesis, 46, 
XY disorder of sex development and complete androgen 
insensitivity.
Conclusion
We report a possible case of Swyer syndrome with 
ambiguous genitalia, who was diagnosed as having 46 XY 
genotype at the age of 23 years and lost to follow up for 
the next 2  years presenting with advanced (stage IIIC) 
germ cell tumor emphasizing the need of close monitor-
ing of these type of patients by a multidisciplinary team. 
The clinical picture fits to the 46, XY CGD, but opens this 
presentation to a new entity in the classification of dis-
orders of sex development, since linked with ambiguous 
genitalia and should be further evaluated.
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